Cited by 38Genomics and Rare DiseasesGenetic Associations and EpidemiologyEvolution and Genetic Dynamics

A minimal role for synonymous variation in human disease

Open access
Dhindsa, Ryan S., Wang, Quanli, Vitsios, Dimitrios, Burren, Oliver S., Hu, Fengyuan, DiCarlo, James E., Kruglyak, Leonid, MacArthur, Daniel G. +2 more·2022·The American Journal of Human Genetics

Published version of a preprint

Abstract

Synonymous mutations change the DNA sequence of a gene without affecting the amino acid sequence of the encoded protein. Although some synonymous mutations can affect RNA splicing, translational efficiency, and mRNA stability, studies in human genetics, mutagenesis screens, and other experiments and evolutionary analyses have repeatedly shown that most synonymous variants are neutral or only weakly deleterious, with some notable exceptions. Based on a recent study in yeast, there have been claims that synonymous mutations could be as important as nonsynonymous mutations in causing disease, assuming the yeast findings hold up and translate to humans. Here, we argue that there is insufficient evidence to overturn the large, coherent body of knowledge establishing the predominant neutrality of synonymous variants in the human genome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2022.10.016

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There were only three significant gene-level cis-CDS pQTLs in the synonymous collapsing model.

    “Moreover, there were only three significant gene-level cis-CDS pQTLs in the synonymous (syn) collapsing model19,20 (full definitions of collapsing models can be found in Extended Data Table 1).”

    From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [20]

    The Methods section describes a synonymous-variant gene-based collapsing model, supporting the model cited in the sentence. But the reported results concern UK Biobank clinical phenotypes, not cis-CDS pQTLs; the paper does not support the count of three significant pQTLs. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [2]2. Shen, X., Song, S., Li, C. & Zhang, J. Synonymous mutations in representative yeast genes are mostly strongly non-neutral. Nature 1–7 (2022) doi:10.1038/s41586-022-04823-w. · DOI · Paper page

Cited by

Sorted by citations

Authors
Dhindsa, R. S., Wang, Q., Vitsios, D., Burren, O. S., Hu, F., DiCarlo, J. E., Kruglyak, L., MacArthur, D. G., Hurles, M. E., & Petrovski, S.
Affiliations
  • Baylor College of Medicine (US)
  • AstraZeneca (United States) (US)
  • AstraZeneca (United Kingdom) (GB)
  • Brigham and Women's Hospital (US)
  • Howard Hughes Medical Institute (US)
  • Broad Institute (US)
  • Wellcome Sanger Institute (GB)
Corresponding author
  • Dhindsa, Ryan S.
  • Petrovski, Slavé
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2022-12
Volume
109
Issue
12
Pages
2105-2109
ISSN
0002-9297 (ISSN-L)
OpenAlex
W4310783369
Cited by
38
References
2
Citations by year
2026: 7 · 2025: 9 · 2024: 10 · 2023: 9 · 2022: 3
FWCI
4.68
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders
National Institute of Neurological Disorders and Stroke (F32 NS127854)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
synonymous mutations, human disease, deleterious mutations, RNA splicing, translation efficiency, mRNA stability, non-synonymous mutations
MeSH terms
Amino Acid Sequence, Biological Evolution, Humans, Mutation, Saccharomyces cerevisiae, Genome, Human

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review